Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy

NCT05673850 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05673850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05673850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy
Lead sponsor
Peking University
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
October 1, 2022
Enrollment
518 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms